Back to top

Twist Bioscience Reaffirmed at Buy as Strong AI-Driven Growth Outlook Supports Unchanged $120 Price Target

Analyst Kyle Mikson CFA from Canaccord Genuity maintained a Buy rating on Twist Bioscience and keeping the price target at $120.00. Kyle Mikson CFA...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Twist Bioscience Corporation (TWST)